GB201813531D0 - Modified liposomes for use in the treatment of haemophilia - Google Patents

Modified liposomes for use in the treatment of haemophilia

Info

Publication number
GB201813531D0
GB201813531D0 GBGB1813531.9A GB201813531A GB201813531D0 GB 201813531 D0 GB201813531 D0 GB 201813531D0 GB 201813531 A GB201813531 A GB 201813531A GB 201813531 D0 GB201813531 D0 GB 201813531D0
Authority
GB
United Kingdom
Prior art keywords
haemophilia
treatment
modified liposomes
liposomes
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1813531.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cantab Biopharmaceuticals Patents Ltd
Original Assignee
Cantab Biopharmaceuticals Patents Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cantab Biopharmaceuticals Patents Ltd filed Critical Cantab Biopharmaceuticals Patents Ltd
Priority to GBGB1813531.9A priority Critical patent/GB201813531D0/en
Publication of GB201813531D0 publication Critical patent/GB201813531D0/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
GBGB1813531.9A 2018-08-20 2018-08-20 Modified liposomes for use in the treatment of haemophilia Ceased GB201813531D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1813531.9A GB201813531D0 (en) 2018-08-20 2018-08-20 Modified liposomes for use in the treatment of haemophilia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1813531.9A GB201813531D0 (en) 2018-08-20 2018-08-20 Modified liposomes for use in the treatment of haemophilia

Publications (1)

Publication Number Publication Date
GB201813531D0 true GB201813531D0 (en) 2018-10-03

Family

ID=63668070

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1813531.9A Ceased GB201813531D0 (en) 2018-08-20 2018-08-20 Modified liposomes for use in the treatment of haemophilia

Country Status (1)

Country Link
GB (1) GB201813531D0 (en)

Similar Documents

Publication Publication Date Title
HK1258396A1 (en) Cenicriviroc combination therapy for the treatment of fibrosis
IL272300A (en) Mavacamten for use in the treatment of hypertrophic cardiomyopathy
IL290150A (en) Compositions and methods for the treatment of chronic pain
HK1257588A1 (en) Medicine for preventing and treating lung fibrosis and use of the medicine
IL246855A0 (en) Agents for use in the treatment of retinal inflammation
IL274363B1 (en) Use of specific sirna against protein s for the treatment of hemophilia
IL272121A (en) Composition and methods for the treatment of myopia
HK1256164A1 (en) Agents for use in the treatment of glioma
IL281997A (en) Combination therapy for the treatment of uveal melanoma
IL277805A (en) Use of gaboxadol in the treatment of substance use disorders
IL269121A (en) Usl-311 for use in the treatment of cancer
EP3199163A4 (en) Composition of doxycycline in liposomes for the prevention, improvement and/or treatment of ocular pathologies
HK1257591A1 (en) Medicine for preventing and treating pathologic kidney tissue damage and use of the medicine
IL289371A (en) Methylthioninium for use in the treatment of synaptopathies
SI3668856T1 (en) Novel tetrazole compounds and their use in the treatment of tuberculosis
ZA202006886B (en) R-fadrozole for use in the treatment of aldostonerism
IL273863B1 (en) Device for use in the treatment of hemorrhoids
GB201813531D0 (en) Modified liposomes for use in the treatment of haemophilia
EP3648789C0 (en) Mtmr2-s polypeptide for use in the treatment of myopathies
GB201905796D0 (en) Modified liposomes for use in the treatment of haemophilia
IL259383A (en) Compound for use in the prevention and treatment of neurodegenerative diseases
GB201820455D0 (en) Compounds and their use for the treatment of alpha1-antitryspin deficiency
GB201820451D0 (en) Compounds and their use for the treatment of alpha1-antitryspin deficiency
GB201820452D0 (en) Compounds and their use for the treatment of alpha1-antitryspin deficiency

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)